Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.024
Sell
RSI(14)
43.343
Neutral
STOCH(KDJ)(9,3,3)
9.496
Oversold
ATR(14)
0.304
Low Volatility
CCI(14)
-65.704
Neutral
Williams %R
91.538
Oversold
TRIX(12,20)
-0.505
Sell
StochRSI(14)
93.751
Buy
Search
Agape ATP Corp
ATPCAdd to Watchlist
2.210USD
+0.030+1.38%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
2.21MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Agape ATP Corp
Currency: USD Updated: 2026-05-15Key Insights
Agape ATP Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 157 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Agape ATP Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Agape ATP Corp Highlights
StrengthsRisks
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.52M.
Overvalued
The company’s latest PE is -0.02, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 9.08K shares, increasing 37.91% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of Agape ATP Corp is 6.19, ranking 160 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 273.66K, representing a year-over-year decrease of 5.32%, while its net profit experienced a year-over-year decrease of 51.23%.
Score
Financials
6.29
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.86
Operational Efficiency
4.63
Growth Potential
6.08
Shareholder Returns
7.08
Agape ATP Corp's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of Agape ATP Corp is 6.73, ranking 151 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.02, which is -11.32% below the recent high of -0.01 and -481454.09% above the recent low of -76.57.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 157/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15No earnings forecast score is currently available for Agape ATP Corp. The Healthcare Equipment & Supplies industry's average is 7.80.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of Agape ATP Corp is 5.72, ranking 171 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.07 and the support level at 1.67, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.200
Buy
MA10
2.428
Sell
MA20
2.359
Sell
MA50
2.697
Sell
MA100
3.146
Sell
MA200
31.195
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-15Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Agape ATP Corp is 1.04, ranking 198 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+97.81%
240-Day Volatility
+240.89%
Return
Best Daily Return
60 days
+87.13%
120 days
+164.56%
5 years
--
Worst Daily Return
60 days
-32.83%
120 days
-94.83%
5 years
--
Sharpe Ratio
60 days
+1.06
120 days
+0.27
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+97.81%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.99
3 years
--
5 years
--
Skewness
240 days
+4.35
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+240.89%
5 years
--
Standardised True Range
240 days
+130.36%
5 years
--
Downside Risk-Adjusted Return
120 days
+48.69%
240 days
+48.69%
Maximum Daily Upside Volatility
60 days
+357.99%
Maximum Daily Downside Volatility
60 days
+167.65%
Liquidity
Average Turnover Rate
60 days
+4.19%
120 days
+41.68%
5 years
--
Turnover Deviation
20 days
-99.86%
60 days
-94.40%
120 days
-44.27%
Peer Comparison
Healthcare Equipment & Supplies
Agape ATP Corp
ATPC
4.11 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
